Castilla-La Mancha launches adult vaccination campaign through March 2027
Castilla-La Mancha launched its regional adult vaccination campaign on October 7, 2026, delivering trivalent influenza and COVID-19 immunizations across primary care centers and public hospitals with an operational window extending through March 31, 2027.
- The regional vaccination campaign runs from October 7, 2026, through March 31, targeting adults aged 60 and older, pregnant individuals, healthcare workers, and vulnerable populations.
- Health authorities distributed 36,000 vaccine doses in the province of Cuenca alone, matching prior immunization benchmarks while introducing updated trivalent formulations aligned with World Health Organization strain recommendations.
- Administrations incorporate co-administered boosters for COVID-19, pneumococcal disease, herpes zoster, and respiratory syncytial virus depending on patient age brackets and clinical risk factors.
Albacete Health Officials Deploy Regional Vaccination Outreach
The coordinated public health initiative involves the Provincial Council of Albacete, the regional Health Delegation, and the Castilla-La Mancha Society of Geriatrics and Gerontology (SCMGG). Provincial health officials distributed more than 36 health centers, 96 clinics, five public hospitals, and the Faculty of Nursing at the University of Castilla-La Mancha (UCLM). The regional government deployed active outreach strategies, utilizing digital channels, SMS notifications to at-risk populations and parents, and appointment scheduling through the digital health application Mi salud digital, as detailed by the Government of Castilla-La Mancha.
Early Respiratory Infections Prompt Trivalent Vaccine Rollout
The early rollout of the immunization schedule was necessitated by a premature rise in respiratory infections and hospital admissions, with health authorities anticipating peak transmission rates prior to the Christmas holiday period. Public health directors confirmed that available influenza vaccines are trivalent to target circulating viral vectors identified by the World Health Organization. The clinical guidelines stratify protection by age cohorts. Adults aged 60 and older receive annual influenza vaccinations. Individuals 65 and older receive updates for diphtheria-tetanus, pneumococcal disease, and herpes zoster. Annual COVID-19 boosters are integrated for patients aged 70 and above, while populations aged 80 and older receive targeted protection against influenza and herpes zoster.
High Risk Cohorts Receive Targeted Immunization Doses
Public health administrators emphasized outreach to high-risk cohorts, including chronic patients, immunocompromised individuals, pregnant women, and essential workers such as firefighters and security forces. In Albacete, the provincial administration targeted approximately 3,000 residents enrolled in the Home Help Service program, where over 97 percent of participants exceed 60 years of age. In the province of Cuenca, health officials distributed 36,000 doses, sustaining a historical coverage rate exceeding 63 percent among adults over 60.
Public health representatives reiterated that vaccine formulations undergo continuous evaluation to maximize efficacy and minimize adverse events. In addition to seasonal influenza and COVID-19 vectors, health centers incorporated immunization protocols against the respiratory syncytial virus (RSV) for institutionalized nursing home residents. Academic evaluation of these preventive measures remains central to regional medical conferences, including the upcoming 25th Congress of the Castilla-La Mancha Society of Geriatrics and Gerontology scheduled for March 2027 at the Albacete provincial headquarters.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.